Last reviewed · How we verify
NCT03742635
Applying Prechtl's Assessment of General Movements for Preterm Infants Through Telemedicine
NA trial testing General Movements Assessment in Infant, Premature in 67 participants. Completed in 28 February 2023.
24 January 2023
Quick facts
| Lead sponsor | University of California, Davis |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 67 |
| Start date | 9 January 2019 |
| Primary completion | 24 January 2023 |
| Estimated completion | 28 February 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- General Movements Assessment
Conditions studied
- Infant, Premature — all drugs for Infant, Premature →
Sponsor
University of California, Davis
Who can join
Under 32 Weeks, any sex, with Infant, Premature. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators will implement a study to evaluate the hypothesis that applying General Movements Assessments (GMA) in a telemedicine setting with real-time scoring is feasible and comparable to scoring video recordings.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03742635
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Infant, Premature
Currently open trials in the same condition.
- NCT07045402 — Effect of Developmental Care on Comfort, Growth, and Oral Feeding Transition in Preterm Infants · NA · recruiting
- NCT06726226 — Extremely Preterm Respiratory Outcome Cohort · recruiting
- NCT03456336 — Management of the PDA Trial · Phase 3 · active not recruiting
- NCT02738411 — Influence of Intestinal Microbiota Implantation in Preterm Infants on Microbiota and Immune Orientation at 3 Years · active not recruiting
- NCT00009633 — Follow-up Visit of High Risk Infants · recruiting
Other University of California, Davis trials
Trials by the same sponsor.
- NCT07024498 — Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment · NA · not yet recruiting
- NCT07322133 — Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE) · Phase 4 · recruiting
- NCT07384767 — Efficacy and Safety of Topical Timolol in Secondary Intention Surgical Wounds Healing · Phase 2 · not yet recruiting
- NCT07267494 — Image-Guided Herniorrhaphy Study · NA · not yet recruiting
- NCT04614714 — Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants · Phase 2, PHASE3 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03742635 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, Davis
- Last refreshed: 24 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03742635.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing